Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Albert M. Maguire, Manzar Ashtari et al.|The Lancet|2016Cited by 464
The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 GeneDaniel C. Chung, Kathleen Z. Reape, Mette Bertelsen et al.|American Journal of Ophthalmology|2018Cited by 135